Corporate Symposia

SUNDAY 24 SEPTEMBER

 

VALUE OF IMMUNOGLOBULINS IN THE MANAGEMENT OF INFECTIOUS DISEASES AND DONOR SPECIFIC ANTIBODIES - Organized by Biotest
Please click here for the programme

Room no. 114 / Sunday 24th September, 2017 / 13:00 – 14:30

Chair: Florian Wagner, Hamburg (Germany)

  • Strategies for prevention of CMV disease in thoracic patients
    Florian Wagner, Hamburg, Germany
  • Successful treatment of early DSA after lung transplantation with IgM-enriched human intravenous immunoglobulins
    Fabio Ius, Hannover, Germany
  • Prevention of HBV recurrence in liver Tx patients with HBIGs
    Frederik Nevens, Leuven, Belgium

 

* * * * * * * * * * * * * * * * * * * * * * * * *

Luncheon Symposium - Organized by Immucor
Please click here for the programme

Room no. 118/119 / Sunday 24th September, 2017 / 13:00 – 14:30

  • “Procare, a Dutch multicentric study to determine the clinical relevance of pre-transplant DSA”
    F. H. J. Claas, Immunogenetics & Transplantation - LUMC, The Netherlands
  • “Latest developments in renal post-transplant monitoring”
    Michael Spigarelli, VP Medical Affairs, Immucor 

 

* * * * * * * * * * * * * * * * * * * * * * * * *

MONDAY 25 SEPTEMBER

 

DIFFERENT PATIENTS, DIFFERENT NEEDS. CAN WE DO MORE? - Organized by Chiesi
Please click here for the programme

Room no. 115 / Monday 25th September , 2017 / 13:00 – 14:00

Chair: Julio Pascual - Spain

  • Patients with “recognised” sensitivity to tacrolimus pharmacokinetics: risk factors and implications for treatment
    Lucrezia Furian, Padua (Italy)
  • Patients with “hidden” sensitivity to tacrolimus pharmacokinetics: identification and management
    Klemens Budde, Berlin (Germany)

 

* * * * * * * * * * * * * * * * * * * * * * * * *

PRECISION MEDICINE IN TRANSPLANTATION: Reclassifying Graft Rejection and Injury with the Molecular Microscope - Organized by One Lambda

Please click here for the programme

Room no. 116 / Monday 25th September, 2017 / 13:00 – 14:30

Moderator: John J. Friedewald, MD - Northwestern University Feinberg School of Medicine

Presenters:  

  • Philip F. Halloran MD, Ph.D - Alberta Transplant Applied Genomics Centre
  • Georg Bohmig, MD - Medical University of Vienna
  • Carmen Lefaucheur, MD, Ph.D - Paris Transplant Group
  • Luciano Potena, MD, Ph.D - University of Bologna
  • Andreas Zuckermann, MD - Medical University of Vienna
  • Antoine Roux, MD, PhD. - Foch Hospital of Paris

 

* * * * * * * * * * * * * * * * * * * * * * * * *

IMMUNOSUPPRESSIVE DRUG MONITORING: THE RIGHT DOSE FOR EACH PATIENT - Organized by Sandoz
Please click here for the programme

Room no. 117 / Monday September 25th, 2017 / 13:00 - 14:00

Chair: Pierre MARQUET, Limoges, France
           Marta CRESPO BARRIO, Barcelona, Spain

  • Technical innovations and perspectives in therapeutic drug monitoring
    Pierre MARQUET, Limoges, France
  • Immunosuppressive drug monitoring: a transplant physician’s point-of-view
    Frederick NEVENS, Leuven, Belgium
  • Immunosuppressive drug monitoring: a transplanted patient’s perspective
    Hakan HEDMAN, Sweden
  • Discussion + Q&A session

 

* * * * * * * * * * * * * * * * * * * * * * * * *

TUESDAY 26 SEPTEMBER

 

TRANSFORMING TRANSPLANTATION - Organized by Novartis
Please click here for the programme

Room no. 111/112 Tuesday, 26th September, 2017 / 13:00 - 14:00

Current challenges and future perspectives in renal transplantation

  • An introduction to current challenges and future perspectives in renal transplantation - The TRANSFORM Study
    Chair: Julio Pascual (Spain)
  • Perspectives on patient populations - Living Donors
    Stefan Berger (The Netherlands)
  • How could emerging clinical evidence impact daily treatment options?
    Claudia Sommerer (Germany)

 

* * * * * * * * * * * * * * * * * * * * * * * * *

INFECTION AND REJECTION IN SOLID ORGAN TRANSPLANTATION: IMPROVING OUTCOMES IN CMV & AMR – Organized by RMEI
Please click here for the programme

Room no. 115 / Tuesday 26th September, 2017 / 17:00 – 18:30

  • Welcome and Introductions
    Nassim Kamar
  • AMR: Transplant Glomerulopathy and Emerging Therapies
    Robert A. Montgomery
  • CMV: Overcoming Therapeutic Limitations with Emerging Therapies
    Camille Nelson Kotton
  • Interactive Panel Discussion (Clinical Cases and Current Issues in AMR and CMV Management)
    All faculty
  • Audience Q&A and Discussion
    All faculty

 

* * * * * * * * * * * * * * * * * * * * * * * * *